Phase I study of XL844, a novel Chk1 and Chk2 kinase inhibitor, in combination with gemcitabine in patients with advanced malignancies Meeting Abstract

  

Authors:	Tse, A.; Yazji, S.; Naing, A.; Matthews, D.; Schwartz, G.; Lawhorn, K.; Kurzrock, R.
Abstract Title:	Phase I study of XL844, a novel Chk1 and Chk2 kinase inhibitor, in combination with gemcitabine in patients with advanced malignancies
Meeting Title:	20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title:	EJC Supplements
Volume:	6
Issue:	12
Meeting Dates:	2008 Oct 21-24
Meeting Location:	Geneva, Switzerland
ISSN:	1359-6349
Publisher:	Pergamon-Elsevier Science Ltd
Date Published:	2008-10-01
Start Page:	124
Language:	English
ACCESSION:	WOS:000261221200394
DOI:	10.1016/s1359-6349(08)72329-2
PROVIDER:	wos
Notes:	--- - Meeting Abstract: 395 - Poster - 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - OCT 21-24, 2008 - Geneva, SWITZERLAND - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/24413